Metabolix (MBLX) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Metabolix Announces Fourth Quarter and Full Year 2014 Financial Results
March 19, 2015 4:05 PM EDTCAMBRIDGE, Mass., March 19, 2015 (GLOBE NEWSWIRE) -- Metabolix, Inc. (Nasdaq: MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months and full year ended December 31, 2014.
"In 2014 we began implementing a plan to reshape Metabolix into a specialty biopolymers company," said Joe Shaulson, president and CEO of Metabolix. "We focused our strategy on commercializing our PHA biopolymers as performance additives in high value applications. We also restructured our U.S. organization, sold our German operations and raised $25 million in a private placement... More
